Ketoprofen topical - Achelios Therapeutics
Alternative Names: ELS M11; Ketoprofen 2% gel – Achelios Therapeutics; Ketoprofen 5% gel – Achelios Therapeutics; Ketoprofen liquid spray – Achelios Therapeutics; Topofen™Latest Information Update: 04 Oct 2022
Price :
$50 *
At a glance
- Originator Achelios Therapeutics
- Class Analgesics; Antirheumatics; Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
- Mechanism of Action Lipoxygenase-cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase II Migraine; Temporomandibular joint dysfunction syndrome
- Discontinued Osteoarthritis; Sprains
Most Recent Events
- 04 Oct 2022 Discontinued - Phase-I for Osteoarthritis in USA (Topical) (Achelios Therapeutics pipeline, October 2022)
- 04 Oct 2022 Discontinued - Preclinical for Sprains in USA (Topical) (Achelios Therapeutics pipeline, October 2022)
- 04 Oct 2022 Phase-II clinical trials in Temporomandibular joint dysfunction syndrome in USA (Topical) Before 2022 (Achelios Therapeutics pipeline, October 2022)